0001144204-17-044236.txt : 20170818 0001144204-17-044236.hdr.sgml : 20170818 20170818184826 ACCESSION NUMBER: 0001144204-17-044236 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170817 FILED AS OF DATE: 20170818 DATE AS OF CHANGE: 20170818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mehren Lawrence CENTRAL INDEX KEY: 0001388833 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31822 FILM NUMBER: 171041948 MAIL ADDRESS: STREET 1: 1910 E. INNOVATION PARK DRIVE CITY: TUCSON STATE: AZ ZIP: 85755 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Accelerate Diagnostics, Inc CENTRAL INDEX KEY: 0000727207 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 841072256 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 BUSINESS PHONE: 303-863-8088 MAIL ADDRESS: STREET 1: 3950 S. COUNTRY CLUB ROAD #470 STREET 2: BUILDING 3-307 CITY: TUCSON STATE: AZ ZIP: 85714 FORMER COMPANY: FORMER CONFORMED NAME: ACCELR8 TECHNOLOGY CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: HYDRO SEEK INC DATE OF NAME CHANGE: 19880802 4 1 v473703_4.xml OWNERSHIP DOCUMENT X0306 4 2017-08-17 0 0000727207 Accelerate Diagnostics, Inc AXDX 0001388833 Mehren Lawrence C/O ACCELERATE DIAGNOSTICS, INC. 3950 S. COUNTRY CLUB ROAD, SUITE 470 TUCSON AZ 85714 1 1 0 0 PRESIDENT AND CEO Common Stock 2017-08-17 4 S 0 223215 22.40 D 762381 D Employee Stock Option (right to buy) 12.49 2017-03-18 2026-03-18 Common Stock 10408 D Employee Stock Option (right to buy) 12.49 2026-03-18 Common Stock 60000 D Employee Stock Option (right to buy) 14.92 2015-02-26 2024-02-26 Common Stock 52132 D Employee Stock Option (right to buy) 1.04 2022-04-20 Common Stock 2200000 D The reporting person contributed AXDX common stock to an exchange fund in exchange for shares of the exchange fund. The AXDX common stock was valued at $22.40 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person. The shares were contributed pursuant to a Rule 10b5-1 plan entered into by the reporting person. No transaction is being reported at this time. This line is only reporting holdings as of the date hereof. The options vest in five (5) equal annual installments on each annivesary of the date of grant beginning on March 18, 2017. 580,000 shares vested immediately upon the date of grant (April 20, 2012); 825,000 shares will vest as follows: 40% (330,000 shares) will vest on the second anniversary of the date of grant, and the remaining 60% (495,000 shares) will vest in 36 equal monthly installments (13,750 shares per month) over the subsequent 36 months; and 795,000 shares will vest as follows (provided that both criteria must be satisfied): (i) 40% (318,000 shares) will vest on the second anniversary of the date of grant, and the remaining 60% (477,000 shares) will vest in 36 equal monthly installments (13,250 shares per month) over the subsequent 36 months, and (ii) 50% (397,500 shares) will vest when at least 50% of the warrants initially issued to Abeja have been exercised by the holder(s) thereof, and the remaining 50% (397,500 shares) will vest when at least 90% of such warrants have been exercised by the holder(s) thereof. /s/ David Hinnant, attorney-in-fact 2017-08-18